AlzChem Group AG
NCN-based specialty chemicals for pharma, nutrition, agriculture, and industrial markets.
ACT | F
Overview
Corporate Details
- ISIN(s):
- DE000A2YNT30
- LEI:
- 8945004EL7WZK3ERG181
- Country:
- Germany
- Address:
- Dr.-Albert-Frank-Str. 32, 83308 Trostberg
- Website:
- https://www.alzchem.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of basic chemicals, fertilizers and nitrogen compounds, plastics and synthetic rubber in primary forms
Description
AlzChem Group AG is a globally active, vertically integrated specialty chemicals company with a leading position in select niche markets. The company's production is centered on the NCN (calcium carbide/calcium cyanamide) chemical chain, from which it develops and manufactures a diverse portfolio of fine and specialty chemical products. Its offerings serve a wide range of industries, including human and animal nutrition, pharmaceuticals, agriculture, fine chemistry, metallurgy, and renewable energy. Key products include high-purity guanidine salts for diagnostic and pharma applications (Bioselect®), creatine precursors for animal feed (Creamino®), and agricultural solutions (Eminex®). AlzChem also provides custom synthesis services and is committed to sustainable corporate governance and achieving climate neutrality.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2025
|
English | 577.3 KB | ||
| 2025-10-30 06:55 |
Earnings Release
Successful nine-month results for 2025: Alzchem Group AG increases EBITDA by 12…
|
English | 11.0 KB | ||
| 2025-10-20 19:21 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.3 KB | ||
| 2025-10-20 10:45 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.3 KB | ||
| 2025-10-15 16:04 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | ||
| 2025-10-13 13:15 |
Regulatory News Service
Alzchem Group AG and Ehrmann launch cooperation: New high-protein creatine prod…
|
English | 9.7 KB | ||
| 2025-10-09 09:52 |
Regulatory News Service
Alzchem Group AG remains in the game: Creapure and FC Bayern Basketball continu…
|
English | 8.2 KB | ||
| 2025-09-12 13:06 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | ||
| 2025-09-05 13:50 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | ||
| 2025-09-02 16:20 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | ||
| 2025-08-05 09:36 |
Major Shareholding Notification
|
English | 12.9 KB | ||
| 2025-08-01 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 692.4 KB | ||
| 2025-07-30 06:55 |
Earnings Release
Alzchem Group AG continues growth trajectory in the first half of 2025 forecas…
|
English | 9.7 KB | ||
| 2025-07-23 13:19 |
Report Publication Announcement
|
English | 3.9 KB | ||
| 2025-07-23 00:00 |
Report Publication Announcement
Datum:23.07.2025
|
German | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all AlzChem Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AlzChem Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AlzChem Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-15 | Weichselbaumer, Dr. Georg | Board | Buy | None | 152,760.00 EUR |
| 2024-11-14 | Niedermaier, Herr Andreas | Board | Buy | None | 101,840.00 EUR |
| 2024-11-14 | Lösler, Andreas | Board | Buy | None | 81,472.00 EUR |
| 2024-11-14 | Englmaier, Klaus Dieter | Board | Buy | None | 76,380.00 EUR |
| 2024-11-12 | Englmaier, Klaus Dieter | Board | Buy | None | 45,209.40 EUR |
| 2024-11-12 | Englmaier, Klaus Dieter | Board | Buy | None | 35,227.00 EUR |
